| scholarly article | Q13442814 |
| P50 | author | Joseph Kwan | Q39381123 |
| Sebastiano Galantucci | Q57144199 | ||
| Francesco Corea | Q58356607 | ||
| P2093 | author name string | Giancarlo Comi | |
| Gharib Fawi | |||
| Albrecht Guenther | |||
| Mohammed Abdalla Abbas | |||
| P2860 | cites work | Aspirin inhibits Chlamydia pneumoniae-induced nuclear factor-kappa B activation, cytokine expression, and bacterial development in human endothelial cells | Q28193411 |
| Atherosclerosis, inflammation, and infection | Q33843534 | ||
| Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions | Q33935055 | ||
| Periodontal infections and cardiovascular disease--how strong is the association? | Q34252421 | ||
| Do pathogens accelerate atherosclerosis? | Q34389205 | ||
| Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project | Q34457169 | ||
| Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: report of 2 cases and literature review | Q35136023 | ||
| Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile | Q35370873 | ||
| Oral health, atherosclerosis, and cardiovascular disease | Q35969365 | ||
| Induction of endothelial cell damage by hCMV molecular mimicry | Q35998281 | ||
| Dental infections and cardiovascular diseases: a review | Q36309250 | ||
| The effect of infections and vaccinations on stroke risk | Q36390814 | ||
| Infection as a risk factor for infarction and atherosclerosis | Q36845622 | ||
| Platelet activation In mice and human Helicobacter pylori infection | Q37371480 | ||
| Discovery of a vaccine antigen that protects mice from Chlamydia pneumoniae infection. | Q37860486 | ||
| Dual role of infections as risk factors for coronary heart disease | Q37862040 | ||
| Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. | Q37863289 | ||
| Nuclear Factor–κB Activation in Endothelium byChlamydia pneumoniaewithout Active Infection | Q37868428 | ||
| Human cytomegalovirus seropositivity is associated with impaired vascular function | Q37868861 | ||
| Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis | Q72209255 | ||
| Central nervous system vasculitis in cytomegalovirus infection | Q72906558 | ||
| Thrombotic thrombocytopenic purpura and cytomegalovirus infection in an immunocompetent adult | Q74050987 | ||
| Risk factor modification in stroke prevention: the experience of a stroke clinic | Q77765082 | ||
| IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis | Q79285484 | ||
| Predisposition to carotid atherosclerosis in ICARAS dental substudy | Q79365786 | ||
| Cytomegalovirus-associated venous thromboembolism in renal transplant recipients: a report of 7 cases | Q79927597 | ||
| Associations between IgG antibody to oral organisms and carotid intima-medial thickness in community-dwelling adults | Q81746753 | ||
| Effects of chronic microbial infection on atherosclerosis | Q82873466 | ||
| Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans? | Q37871004 | ||
| Immune activation as effect modifier of atherogenesis in chronic infection | Q37871384 | ||
| Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model | Q37871579 | ||
| Predisposition to atherosclerosis by infections: role of endothelial dysfunction | Q37871635 | ||
| Effect of macrolide antibiotics on human endothelial cells activated by Chlamydia pneumoniae infection and tumor necrosis factor-alpha | Q37871907 | ||
| Link between intracellular pathogens and cardiovascular diseases. | Q37872469 | ||
| Chlamydia pneumonia seropositivity correlates with serum fibrinogen and lipoprotein a levels: any role in atherosclerosis? | Q37873857 | ||
| Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease | Q37875480 | ||
| Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels | Q37875829 | ||
| Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis | Q37875835 | ||
| Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells | Q37877296 | ||
| Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis | Q37877720 | ||
| Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study | Q37878753 | ||
| Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd | Q37878769 | ||
| Chlamydia pneumoniae antibodies associated with altered serum lipid profile | Q37878800 | ||
| Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension | Q37879204 | ||
| New macrolides | Q37880043 | ||
| Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction | Q37880581 | ||
| Distribution of Chlamydia pneumoniae infection in the athersclerotic carotid artery | Q37881215 | ||
| Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile | Q37881987 | ||
| Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery | Q37882074 | ||
| Chlamydia species infect human vascular endothelial cells and induce procoagulant activity | Q37883093 | ||
| Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms | Q37883353 | ||
| Association of chlamydial infection with cerebrovascular disease | Q37884018 | ||
| The immunobiology and immunopathology of chlamydial infections | Q37886284 | ||
| Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors | Q37886448 | ||
| Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators | Q37890128 | ||
| Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease | Q37891247 | ||
| Newer methods for diagnosis of cytomegalovirus infection | Q37897919 | ||
| Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease | Q40701818 | ||
| The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis | Q40899518 | ||
| Asymptomatic carotid lesions: traditional vs. emerging risk factors. | Q43418129 | ||
| Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis | Q45108781 | ||
| A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study | Q45741610 | ||
| Mechanisms of injury to the central nervous system following experimental cytomegalovirus infection | Q46377458 | ||
| Is there a possible relation between atrophic gastritis and premature atherosclerosis? | Q46816075 | ||
| Porphyromonas gingivalis-induced platelet aggregation in plasma depends on Hgp44 adhesin but not Rgp proteinase | Q46854879 | ||
| Anti-cytomegalovirus (CMV) IgG antibody titer in patients with risk factors to atherosclerosis. | Q51532867 | ||
| Surrogate sonographic markers of atherosclerosis. | Q51940575 | ||
| Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy. | Q52947848 | ||
| Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes | Q57192476 | ||
| CMV and Transplant-Related Coronary Atherosclerosis: An Immunohistochemical, In Situ Hybridization and Polymerase Chain Reaction In Situ Study | Q58854154 | ||
| High seroprevalence of Helicobacter pylori infection in coronary heart disease | Q59510000 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 20-24 | |
| P577 | publication date | 2008-05-07 | |
| P1433 | published in | The open neurology journal | Q27722068 |
| P1476 | title | Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutical options | |
| P478 | volume | 2 |
| Q44685855 | Human cytomegalovirus-IgM seropositivity is not associated with atherogenic alterations of lipid profiles and inflammatory status in ischemic stroke patients: a preliminary study |
| Q87331371 | Modest correlation between serum neopterin levels and Gensini scores in a cohort of patients undergoing coronary angiography |
Search more.